Evaluation of metabolic syndrome and related factors in children affected by acute lymphoblastic leukemia

Introduction: Obesity is among the medical problems in survivors of childhood acute lymphoblastic leukemia (ALL). These patients are at risk of metabolic syndrome (MS). The present study aimed to follow the patients with ALL regarding the incidence of MS. Patients and Methods: This study was conduct...

Full description

Saved in:
Bibliographic Details
Main Authors: Soheila Zareifar, Sezaneh Haghpanah, Eslam Shorafa, Nader Shakibazad, Zohreh Karamizadeh
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2017-01-01
Series:Indian Journal of Medical and Paediatric Oncology
Subjects:
Online Access:http://www.ijmpo.org/article.asp?issn=0971-5851;year=2017;volume=38;issue=2;spage=97;epage=102;aulast=Zareifar
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849738270610554880
author Soheila Zareifar
Sezaneh Haghpanah
Eslam Shorafa
Nader Shakibazad
Zohreh Karamizadeh
author_facet Soheila Zareifar
Sezaneh Haghpanah
Eslam Shorafa
Nader Shakibazad
Zohreh Karamizadeh
author_sort Soheila Zareifar
collection DOAJ
description Introduction: Obesity is among the medical problems in survivors of childhood acute lymphoblastic leukemia (ALL). These patients are at risk of metabolic syndrome (MS). The present study aimed to follow the patients with ALL regarding the incidence of MS. Patients and Methods: This study was conducted on all patients who referred to the oncology clinic from July 2012 to July 2013. The exclusion criteria of the study were ALL relapse, secondary malignancy, hypothyroidism, Down syndrome, and below 2 years of age. ALL had to be diagnosed at least 12 months before enrollment into this study. MS was assessed by serum triglyceride, cholesterol, fasting blood sugar, leptin, and insulin levels. Besides, body mass index (BMI) and blood pressure (BP) were measured at diagnosis and at the last visit. Results: This study was conducted on 53 patients (male = 35, female = 18). At the end of the study, 13 patients (24.53%) were overweight compared to 3 patients at diagnosis (P = 0.04). The mean blood leptin level was higher in overweight patients compared to the others (P = 0.001). MS was detected in 21 patients (39.6%), including 12 males and 9 females. In addition, the BMI Z- score significantly increased over the study period (P = 0.001). Conclusions: Being overweight is a complication of ALL treatment, which is associated with elevated blood leptin level and BMI Z- score. Therefore, MS criteria, such as BP, weight, and serum triglyceride level, should be taken into account in each visit.
format Article
id doaj-art-55ebdebe70ae4d8a9b0bf3189b9b3887
institution DOAJ
issn 0971-5851
language English
publishDate 2017-01-01
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format Article
series Indian Journal of Medical and Paediatric Oncology
spelling doaj-art-55ebdebe70ae4d8a9b0bf3189b9b38872025-08-20T03:06:40ZengThieme Medical and Scientific Publishers Pvt. Ltd.Indian Journal of Medical and Paediatric Oncology0971-58512017-01-013829710210.4103/ijmpo.ijmpo_69_16Evaluation of metabolic syndrome and related factors in children affected by acute lymphoblastic leukemiaSoheila ZareifarSezaneh HaghpanahEslam ShorafaNader ShakibazadZohreh KaramizadehIntroduction: Obesity is among the medical problems in survivors of childhood acute lymphoblastic leukemia (ALL). These patients are at risk of metabolic syndrome (MS). The present study aimed to follow the patients with ALL regarding the incidence of MS. Patients and Methods: This study was conducted on all patients who referred to the oncology clinic from July 2012 to July 2013. The exclusion criteria of the study were ALL relapse, secondary malignancy, hypothyroidism, Down syndrome, and below 2 years of age. ALL had to be diagnosed at least 12 months before enrollment into this study. MS was assessed by serum triglyceride, cholesterol, fasting blood sugar, leptin, and insulin levels. Besides, body mass index (BMI) and blood pressure (BP) were measured at diagnosis and at the last visit. Results: This study was conducted on 53 patients (male = 35, female = 18). At the end of the study, 13 patients (24.53%) were overweight compared to 3 patients at diagnosis (P = 0.04). The mean blood leptin level was higher in overweight patients compared to the others (P = 0.001). MS was detected in 21 patients (39.6%), including 12 males and 9 females. In addition, the BMI Z- score significantly increased over the study period (P = 0.001). Conclusions: Being overweight is a complication of ALL treatment, which is associated with elevated blood leptin level and BMI Z- score. Therefore, MS criteria, such as BP, weight, and serum triglyceride level, should be taken into account in each visit.http://www.ijmpo.org/article.asp?issn=0971-5851;year=2017;volume=38;issue=2;spage=97;epage=102;aulast=ZareifarAcute lymphoblastic leukemiabody mass indexleptinmetabolic syndromeoverweight
spellingShingle Soheila Zareifar
Sezaneh Haghpanah
Eslam Shorafa
Nader Shakibazad
Zohreh Karamizadeh
Evaluation of metabolic syndrome and related factors in children affected by acute lymphoblastic leukemia
Indian Journal of Medical and Paediatric Oncology
Acute lymphoblastic leukemia
body mass index
leptin
metabolic syndrome
overweight
title Evaluation of metabolic syndrome and related factors in children affected by acute lymphoblastic leukemia
title_full Evaluation of metabolic syndrome and related factors in children affected by acute lymphoblastic leukemia
title_fullStr Evaluation of metabolic syndrome and related factors in children affected by acute lymphoblastic leukemia
title_full_unstemmed Evaluation of metabolic syndrome and related factors in children affected by acute lymphoblastic leukemia
title_short Evaluation of metabolic syndrome and related factors in children affected by acute lymphoblastic leukemia
title_sort evaluation of metabolic syndrome and related factors in children affected by acute lymphoblastic leukemia
topic Acute lymphoblastic leukemia
body mass index
leptin
metabolic syndrome
overweight
url http://www.ijmpo.org/article.asp?issn=0971-5851;year=2017;volume=38;issue=2;spage=97;epage=102;aulast=Zareifar
work_keys_str_mv AT soheilazareifar evaluationofmetabolicsyndromeandrelatedfactorsinchildrenaffectedbyacutelymphoblasticleukemia
AT sezanehhaghpanah evaluationofmetabolicsyndromeandrelatedfactorsinchildrenaffectedbyacutelymphoblasticleukemia
AT eslamshorafa evaluationofmetabolicsyndromeandrelatedfactorsinchildrenaffectedbyacutelymphoblasticleukemia
AT nadershakibazad evaluationofmetabolicsyndromeandrelatedfactorsinchildrenaffectedbyacutelymphoblasticleukemia
AT zohrehkaramizadeh evaluationofmetabolicsyndromeandrelatedfactorsinchildrenaffectedbyacutelymphoblasticleukemia